Structure modeling of all identified G protein-coupled receptors in the human genome

PLoS Computational Biology

Volumn 2, Issue 2, 2006, Pages 88-99

  Zhang, Yang ^a   Devries, Mark E ^a   Skolnick, Jeffrey ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; ENZYME ACTIVITY; MEAN SQUARE ERROR;

CELL SURFACE RECEPTORS; G PROTEIN COUPLED RECEPTORS; HUMAN GENES; HUMAN GENOMES; INTEGRAL MEMBRANE PROTEINS; PREDICTED MODELS; RECEPTOR MODELING; ROOT MEAN SQUARED DEVIATIONS; STRUCTURE MODELS; TRANSMEMBRANE HELIX;

GENES;

DNA FRAGMENT; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; RHODOPSIN;

AFFINITY LABELING; ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; AUTOMATION; COMMERCIAL PHENOMENA; COMPUTER MODEL; COW; DNA TEMPLATE; ERROR; EXTRACELLULAR MATRIX; GENE CLUSTER; GENETIC VARIABILITY; GENOME; INTERNET; MUTAGENESIS; OPEN READING FRAME; PREDICTION; PROBLEM SOLVING; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DATABASE; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; SCORING SYSTEM; SEQUENCE HOMOLOGY; VALIDATION PROCESS; ALGORITHM; ANIMAL; BIOLOGY; CATTLE; CHEMICAL STRUCTURE; CHEMISTRY; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONFORMATION; HUMAN; HUMAN GENOME; METHODOLOGY; PROTEIN CONFORMATION;

BOVINAE;

ALGORITHMS; ANIMALS; CATTLE; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; GENOME, HUMAN; HUMANS; INTERNET; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; SOFTWARE;

EID: 33645793799     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0020013     Document Type: Article

References (120)

1. Watson S, Arkinstall S (1994) The G protein Linked Receptors Facts Book. New York: Academic Press. 427 p.
2. Flower DR (1999) Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422: 207-234.
3. Takeda S, Kadowaki S, Haga T, Takaesu H, Mitaku S (2002) Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 520: 97-101.
4. Collins FS (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
5. Drews J (2000) Drug discovery: A historical perspective. Science 287: 1960-1964.
6. Skolnick J, Fetrow JS, Kolinski A (2000) Structural genomics and its importance for gene function analysis. Nat Biotechnol 18: 283-287.
7. Kuhlbrandt W, Gouaux E (1999) Membrane proteins. Curr Opin Struct Biol 9: 445-447.
8. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739-745.
9. Archer E, Maigret B, Escrieut C, Pradayrol L, Fourmy D (2003) Rhodopsin crystal: New template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol Sci 24: 36-40.
10. Moult J, Fidelis K, Zemla A, Hubbard T (2003) Critical assessment of methods of protein structure prediction (CASP)-round V. Proteins 53 (Suppl 6): 334-339.
11. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
12. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, et al. (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325.
13. Bowie JU, Luthy R, Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253: 164-170.
14. Skolnick J, Kihara D, Zhang Y (2004) Development and large scale benchmark testing of the PROSPECTOR 3.0 threading algorithm. Protein 56: 502-518.
15. Liwo A, Lee J, Ripoll DR, Pillardy J, Scheraga HA (1999) Protein structure prediction by global optimization of a potential energy function. Proc Natl Acad Sci U S A 96: 5482-5485.
16. Simons KT, Kooperberg C, Huang E, Baker D (1997) Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions. J Mol Biol 268: 209-225.
17. Zhang Y, Kolinski A, Skolnick J (2003) TOUCHSTONE II: A new approach to ab initio protein structure prediction. Biophys J 85: 1145-1164.
18. Baker D, Sali A (2001) Protein structure prediction and structural genomics. Science 294: 93-96.
19. Tramontano A, Morea V (2003) Assessment of homology-based predictions in CASP5. Proteins 53 (Suppl 6): 352-368.
20. Zhang Y, Skolnick J (2004) Automated structure prediction of weakly homologous proteins on a genomic scale. Proc Natl Acad Sci U S A 101: 7594-7599.
21. Zhang Y, Skolnick J (2004) Tertiary structure predictions on a comprehensive benchmark of medium to large size proteins. Biophys J 87: 2647-2655.
22. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242.
23. Herzyk P, Hubbard RE (1995) Automated method for modeling sevenhelix transmembrane receptors from experimental data. Biophys J 69: 2419-2442.
24. Filizola M, Perez JJ, Carteni-Farina M (1998) BUNDLE: A program for building the transmembrane domains of G-protein-coupled receptors. J Comput Aided Mol Des 12: 111-118.
25. Bissantz C, Logean A, Rognan D (2004) High-throughput modeling of human G-protein coupled receptors: Amino acid sequence alignment, three-dimensional model building, and receptor library screening. J Chem Inf Comput Sci 44: 1162-1176.
26. Bissantz C, Bernard P, Hibert M, Rognan D (2003) Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 50: 5-25.
27. Shacham S, Marantz Y, Bar-Haim S, Kalid O, Warshaviak D, et al. (2004) PREDICT modeling and in-silico screening for G-protein coupled receptors. Proteins 57: 51-86.
28. Becker OM, Shacham S, Marantz Y, Noiman S (2003) Modeling the 3D structure of GPCRs: advances and application to drug discovery. Curr Opin Drug Disc Dev 6: 353-361.
29. Becker OM, Marantz Y, Shacham S, Inbal B, Heifetz A, et al. (2004) G protein-coupled receptors: In silico drug discovery in 3D. Proc Natl Acad Sci U S A 101: 11304-11309.
30. Sale K, Faulon JL, Gray GA, Schoeniger JS, Young MM (2004) Optimal bundling of transmembrane helices using sparse distance constraints. Prot Sci 13: 2613-2627.
31. Shi L, Javitch JA (2002) The binding site of aminergic G protein-coupled receptors: The transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 42: 437-467.
32. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, et al. (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971-977.
33. Du P, Salon JA, Tamm JA, Hou C, Cui W, et al. (1997) Modeling the Gprotein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Prot Eng 10: 109-117.
34. Zhang Y, Arakaki A, Skolnick J (2005) TASSER: An automated method for the prediction of protein tertiary structures in CASP6. Proteins: In press.
35. Zhang Y, Skolnick J (2005) TM-align: A protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 33: 2302-2309.
36. Zhang Y, Skolnick J (2005) The protein structure prediction problem could be solved using the current PDB library. Proc Natl Acad Sci U S A 102: 1029-1034.
37. Zhang Y, Skolnick J (2004) SPICKER: A clustering approach to identify near-native protein folds. J Comput Chem 25: 865-871.
38. Jones DT, Taylor WR, Thornton JM (1994) A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33: 3038-3049.
39. Horn F, Weare J, Beukers MW, Horsch S, Bairoch A, et al. (1998) GPCRDB: An information system for G protein-coupled receptors. Nucleic Acids Res 26: 275-279.
40. Bairoch A, Apweiler R (1998) The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998. Nucleic Acids Res 26: 38-42.
41. Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, et al. (2005) CDD: A conserved domain database for protein classification. Nucleic Acids Res 33: D192-D196.
42. Pisarska M, Mulchahey JJ, Sheriff S, Geracioti TD, Kasckow JW (2001) Regulation of corticotropin-releasing hormone in vitro. Peptides 22: 705-712.
43. Chen J, Kuei C, Sutton S, Wilson S, Yu J, et al. (2005) Identification and pharmacological characterization of prokineticin 2beta as a selective ligand for prokineticin receptor 1. Mol Pharmacol 67: 2070-2076.
44. Zhang Y, Skolnick J (2004) Scoring function for automated assessment of protein structure template quality. Proteins 57: 702-710.
45. Tian W, Skolnick J (2003) How well is enzyme function conserved as a function of pairwise sequence identity? J Mol Biol 333: 863-882.
46. Holm L, Sander C (1996) Mapping the protein universe. Science 273: 595-603.
47. Schwartz TW (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol 5: 434-444.
48. Clement M, Martin SS, Beaulieu ME, Chamberland C, Lavigne P, et al. (2005) Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay. J Biol Chem 280: 27121-27129.
49. Huang W, Osman R, Gershengorn MC (2005) Agonist-induced conforma-tional changes in thyrotropin-releasing hormone receptor type I: Disulfide cross-linking and molecular modeling approaches. Biochemistry 44: 2419-2426.
50. Zhang Y, McCurdy CR, Metzger TG, Portoghese PS (2005) Specific crosslinking of Lys233 and Cys235 in the mu opioid receptor by a reporter affinity label. Biochemistry 44: 2271-2275.
51. Higginbottom A, Cain SA, Woodruff TM, Proctor LM, Madala PK, et al. (2005) Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. J Biol Chem 280: 17831-17840.
52. Gavrilin MA, Gulina IV, Kawano T, Dragan S, Chakravarti L, et al. (2005) Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions. Biochem Biophys Res Commun 327: 533-540.
53. Buck E, Bourne H, Wells JA (2005) Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor. J Biol Chem 280: 4009-4012.
54. de Mendonca FL, da Fonseca PC, Phillips RM, Saldanha JW, Williams TJ, et al. (2005) Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist. J Biol Chem 280: 4808-4816.
55. Mazna P, Obsilova V, Jelinkova I, Balik A, Berka K, et al. (2004) Molecular modeling of human MT2 melatonin receptor: The role of Val204, Leu272 and Tyr298 in ligand binding. J Neurochem 91: 836-842.
56. Costanzi S, Mamedova L, Gao ZG, Jacobson KA (2004) Architecture of P2Y nucleotide receptors: Structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 47: 5393-5404.
57. Martin SS, Boucard AA, Clement M, Escher E, Leduc R, et al. (2004) Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis. J Biol Chem 279: 51415-51423.
58. Reinhart GJ, Xie Q, Liu XJ, Zhu YF, Fan J, et al. (2004) Species selectivity of nonpeptide antagonists of the gonadotropin-releasing hormone receptor is determined by residues in extracellular loops II and III and the amino terminus. J Biol Chem 279: 34115-34122.
59. Tchilibon S, Kim SK, Gao ZG, Harris BA, Blaustein JB, et al. (2004) Exploring distal regions of the A3 adenosine receptor binding site: Sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. Bioorg Med Chem 12: 2021-2034.
60. Geng L, Wu J, So SP, Huang G, Ruan KH (2004) Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor. Arch Biochem Biophys 423: 253-265.
61. Fadhil I, Schmidt R, Walpole C, Carpenter KA (2004) Exploring deltorphin II binding to the third extracellular loop of the delta-opioid receptor. J Biol Chem 279: 21069-21077.
62. Hernanz-Falcon P, Rodriguez-Frade JM, Serrano A, Juan D, del Sol A, et al. (2004) Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 5: 216-223.
63. Berkhout TA, Blaney FE, Bridges AM, Cooper DG, Forbes IT, et al. (2003) CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. J Med Chem 46: 4070-4086.
64. Decaillot FM, Befort K, Filliol D, Yue S, Walker P, et al. (2003) Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Biol 10: 629-636.
65. Boucard AA, Roy M, Beaulieu ME, Lavigne P, Escher E, et al. (2003) Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket. J Biol Chem 278: 36628-36636.
66. Klco JM, Lassere TB, Baranski TJ (2003) C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J Biol Chem 278: 35345-35353.
67. Gerdin MJ, Mseeh F, Dubocovich ML (2003) Mutagenesis studies of the human MT2 melatonin receptor. Biochem Pharmacol 66: 315-320.
68. Kokkola T, Foord SM, Watson MA, Vakkuri O, Laitinen JT (2003) Important amino acids for the function of the human MT1 melatonin receptor. Biochem Pharmacol 65: 1463-1471.
69. Gao ZG, Kim SK, Gross AS, Chen A, Blaustein JB, et al. (2003) Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor. Mol Pharmacol 63: 1021-1031.
70. Chaipatikul V, Loh HH, Law PY (2003) Ligand-selective activation of muoid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain. J Pharmacol Exp Ther 305: 909-918.
71. So SP, Wu J, Huang G, Huang A, Li D, et al. (2003) Identification of residues important for ligand binding of thromboxane A2 receptor in the second extracellular loop using the NMR experiment-guided mutagenesis approach. J Biol Chem 278: 10922-10927.
72. Guo W, Shi L, Javitch JA (2003) The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 278: 4385-4388.
73. Mseeh F, Gerdin MJ, Dubocovich MI (2002) Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor. Eur J Pharmacol 449: 29-38.
74. Hamdan FF, Ward SD, Siddiqui NA, Bloodworth LM, Wess J (2002) Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor. Biochemistry 41: 7647-7658.
75. Auger GA, Pease JE, Shen X, Xanthou G, Barker MD (2002) Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression. Eur J Immunol 32: 1052-1058.
76. Turek JW, Halmos T, Sullivan NL, Antonakis K, Le Breton GC (2002) Mapping of a ligand-binding site for the human thromboxane A2 receptor protein. J Biol Chem 277: 16791-106797.
77. Shapiro DA, Kristiansen K, Weiner DM, Kroeze WK, Roth BL (2002) Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 277: 11441-11449.
78. Ward SD, Hamdan FF, Bloodworth LM, Wess J (2002) Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy. J Biol Chem 277: 2247-2257.
79. Kraft K, Olbrich H, Majoul I, Mack M, Proudfoot A, et al. (2001) Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. J Biol Chem 276: 34408-34418.
80. Nardese V, Longhi R, Polo S, Sironi F, Arcelloni C, et al. (2001) Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES. Nat Struct Biol 8: 611-615.
81. Conway S, Mowat ES, Drew JE, Barrett P, Delagrange P, et al. (2001) Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor. Biochem Biophys Res Commun 282: 1229-1236.
82. Youn BS, Yu KY, Alkhatib G, Kwon BS (2001) The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287. Biochem Biophys Res Commun 281: 627-633.
83. Katancik JA, Sharma A, de Nardin E (2000) Interleukin 8, neutrophilactivating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 12: 1480-1488.
84. Tokita K, Hocart SJ, Katsuno T, Mantey SA, Coy DH, et al. (2001) Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368. J Biol Chem 276: 495-504.
85. Chabot DJ, Broder CC (2000) Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry. J Biol Chem 275: 23774-23782.
86. Dragic T, Trkola A, Thompson DA, Cormier EG, Kajumo FA, et al. (2000) A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci U S A 97: 5639-5644.
87. Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, et al. (2000) Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: Binding to a common chemokine receptor motif within the helical bundle. J Biol Chem 275: 25562-25571.
88. Zhou H, Tai HH (2000) Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding. Arch Biochem Biophys 373: 211-217.
89. Han KH, Green SR, Tangirala RK, Tanaka S, Quehenberger O (1999) Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling. J Biol Chem 274: 32055-32062.
90. Miettinen HM, Gripentrog JM, Mason MM, Jesaitis AJ (1999) Identification of putative sites of interaction between the human formyl peptide receptor and G protein. J Biol Chem 274: 27934-27942.
91. Chabot DJ, Zhang PF, Quinnan GV, Broder CC (1999) Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J Virol 73: 6598-6609.
92. Zeng FY, Hopp A, Soldner A, Wess J (1999) Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation. J Biol Chem 274: 16629-16640.
93. Xu W, Ozdener F, Li JG, Chen C, de Riel JK, et al. (1999) Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor. FEBS Lett 447: 318-324.
94. Suetomi K, Lu Z, Heck T, Wood TG, Prusak DJ, et al. (1999) Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes. J Biol Chem 274: 11768-11772.
95. Sainz E, Akeson M, Mantey SA, Jensen RT, Battey JF (1998) Four amino acid residues are critical for high affinity binding of neuromedin B to the neuromedin B receptor. J Biol Chem 273: 15927-15932.
96. Wang ZX, Berson JF, Zhang TY, Cen YH, Sun Y, et al. (1998) CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins. J Biol Chem 273: 15007-15015.
97. Mills JS, Miettinen HM, Barnidge D, Vlases MJ, Wimer-Mackin S, et al. (1998) Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. J Biol Chem 273: 10428-10435.
98. Rabut GE, Konner JA, Kajumo F, Moore JP, Dragic T (1998) Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. J Virol 72: 3464-3468.
99. Dragic T, Trkola A, Lin SW, Nagashima KA, Kajumo F, et al. (1998) Aminoterminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J Virol 72: 279-285.
100. Miettinen HM, Mills JS, Gripentrog JM, Dratz EA, Granger BL, et al. (1997) The ligand binding site of the formyl peptide receptor maps in the transmembrane region. J Immunol 159: 4045-4054.
101. Davidson JS, Assefa D, Pawson A, Davies P, Hapgood J, et al. (1997) Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. Biochemistry 36: 12881-12889.
102. Xie W, Jiang H, Wu Y, Wu D (1997) Two basic amino acids in the second inner loop of the interleukin-8 receptor are essential for Galpha16 coupling. J Biol Chem 272: 24948-24951.
103. Samson M, LaRosa G, Libert F, Paindavoine P, Detheux M, et al. (1997) The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 272: 24934-24941.
104. Brelot A, Heveker N, Pleskoff O, Sol N, Alizon M (1997) Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J Virol 71: 4744-4751.
105. Picard L, Wilkinson DA, McKnight A, Gray PW, Hoxie JA, et al. (1997) Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry. Virology 231: 105-111.
106. Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, et al. (1996) Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87: 437-446.
107. Damaj BB, McColl SR, Neote K, Songqing N, Ogborn KT, et al. (1996) Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J 10: 1426-1434.
108. Chiang N, Kan WM, Tai HH (1996) Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. Arch Biochem Biophys 334: 9-17.
109. D'Angelo DD, Eubank JJ, Davis MG, Dorn GW (1996) Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling. J Biol Chem 271: 6233-6240.
110. Leong SR, Kabakoff RC, Hebert CA (1994) Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J Biol Chem 269: 19343-19348.
111. Hebert CA, Chuntharapai A, Smith M, Colby T, Kim J, et al. (1993) Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J Biol Chem 268: 18549-18553.
112. Ladoux A, Frelin C (2000) Coordinated up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier. J Biol Chem 275: 39914-39919.
113. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272.
114. Vaidehi N, Floriano WB, Trabanino R, Hall SE, Freddolino P, et al. (2002) Prediction of structure and function of G protein-coupled receptors. Proc Natl Acad Sci U S A 99: 12622-12627.
115. Bindewald E, Skolnick J (2005) A scoring function for docking ligands to low-resolution protein structures. J Comp Chem 26: 374-383.
116. Zhang Y, Kihara D, Skolnick J (2002) Local energy landscape flattening: Parallel hyperbolic Monte Carlo sampling of protein folding. Proteins 48: 192-201.
117. Jones DT (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292: 195-202.
118. Feig M, Rotkiewicz P, Kolinski A, Skolnick J, Brooks CL III (2000) Accurate reconstruction of all-atom protein representations from side-chain-based low-resolution models. Proteins 41: 86-97.
119. Reva BA, Finkelstein AV, Skolnick J (1998) What is the probability of a chance prediction of a protein structure with an RMSD of 6 A? Fold Des 3: 141-147.
120. Sayle RA, Milner-White EJ (1995) RASMOL: Biomolecular graphics for all. Trends Biochem Sci 20: 374.